Cited 227 time in
Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cho, Jung Keun | - |
| dc.contributor.author | Curtis-Long, Marcus J. | - |
| dc.contributor.author | Lee, Kon Ho | - |
| dc.contributor.author | Kim, Dae Wook | - |
| dc.contributor.author | Ryu, Hyung Won | - |
| dc.contributor.author | Yuk, Heung Joo | - |
| dc.contributor.author | Park, Ki Hun | - |
| dc.date.accessioned | 2022-12-27T00:33:02Z | - |
| dc.date.available | 2022-12-27T00:33:02Z | - |
| dc.date.issued | 2013-06-01 | - |
| dc.identifier.issn | 0968-0896 | - |
| dc.identifier.issn | 1464-3391 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/20625 | - |
| dc.description.abstract | SARS-CoV papain-like protease (PLpro) is an important antiviral target due to its key roles in SARS virus replication. The MeOH extracts of the fruits of the Paulownia tree yielded many small molecules capable of targeting PLpro. Five of these compounds were new geranylated flavonoids, tomentin A, tomentin B, tomentin C, tomentin D, tomentin E (1-5). Structure analysis of new compounds (1-5) by NMR showed that they all contain a 3,4-dihydro-2H-pyran moiety. This chemotype is very rare and is derived from cyclization of a geranyl group with a phenol functionality. Most compounds (1-12) inhibited PLpro in a dose dependent manner with IC50's raging between 5.0 and 14.4 mu M. All new compounds having the dihydro-2H-pyran group showed better inhibition than their parent compounds (1 vs 11, 2 vs 9, 4 vs 12, 5 vs 6). In kinetic studies, 1-12 emerged to be reversible, mixed inhibitors. (C) 2013 Elsevier Ltd. All rights reserved. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
| dc.title | Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1016/j.bmc.2013.03.027 | - |
| dc.identifier.scopusid | 2-s2.0-84877807370 | - |
| dc.identifier.wosid | 000319002600025 | - |
| dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.21, no.11, pp 3051 - 3057 | - |
| dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
| dc.citation.volume | 21 | - |
| dc.citation.number | 11 | - |
| dc.citation.startPage | 3051 | - |
| dc.citation.endPage | 3057 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
| dc.subject.keywordPlus | RESPIRATORY SYNDROME CORONAVIRUS | - |
| dc.subject.keywordPlus | FLAVANONES | - |
| dc.subject.keywordPlus | VIRUS | - |
| dc.subject.keywordPlus | BATS | - |
| dc.subject.keywordAuthor | SARS-CoV PLpro | - |
| dc.subject.keywordAuthor | Paulownia tomentosa | - |
| dc.subject.keywordAuthor | Geranylated flavonoids | - |
| dc.subject.keywordAuthor | PLpro inhibitor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
